**Core Concept**
Atractiloside is a cardenolide, a type of cardiac glycoside, which is a class of drugs used to treat heart failure and certain arrhythmias. Cardiac glycosides work by inhibiting the sodium-potassium ATPase pump in cardiac cells, leading to increased intracellular sodium and calcium levels, which enhances myocardial contractility and slows heart rate.

**Why the Correct Answer is Right**
Atractiloside acts as a cardiac glycoside by inhibiting the sodium-potassium ATPase pump, also known as the Na+/K+-ATPase pump. This pump is responsible for maintaining the sodium and potassium gradients across the cardiac cell membrane. By inhibiting this pump, atractiloside increases the intracellular sodium concentration, which indirectly increases the intracellular calcium concentration through the sodium-calcium exchange mechanism. The increased intracellular calcium enhances myocardial contractility and slows heart rate, making it a useful treatment for heart failure and certain arrhythmias.

**Why Each Wrong Option is Incorrect**
**Option A:** Atractiloside is not a beta-blocker, which is a class of drugs that works by blocking the effects of epinephrine on the heart, reducing heart rate and blood pressure.

**Option B:** Atractiloside does not act as a calcium channel blocker, which is a class of drugs that works by blocking the influx of calcium ions into cardiac cells, reducing myocardial contractility and heart rate.

**Option C:** Atractiloside is not an anti-arrhythmic drug that works by blocking potassium channels, such as amiodarone or sotalol.

**Clinical Pearl / High-Yield Fact**
Cardiac glycosides like atractiloside are often used in combination with diuretics and vasodilators to manage heart failure, and their use is associated with a risk of digitalis toxicity, which can be life-threatening if not recognized and treated promptly.

**Correct Answer:** D.